CEACAM5 and diabetes mellitus: There was no statistically significant difference in age, sex, smoking and diabetes history, baseline CA199 level, CEA level, NLR, weight loss, lymph node metastasis, and postoperative adjuvant chemotherapy between PHC and PBTC subgroups (P>0.05).